A Child in Crisis
It is said that necessity is the mother of invention, and no one is more driven to invention than the mother of a sick child. On January 14, 2016, Annabelle Manalo brought home her healthy newborn son. Just two hours later, he was in crisis.
He began twitching and foaming at the mouth; he wasn’t feeding and seemed in a trance-like state. Back at the hospital, after a battery of tests and hours of waiting, Annabelle was told that her baby had a massive stroke, and, at just one-month old, he underwent brain surgery. Later, he was diagnosed with severe epilepsy, experiencing back-to-back seizures in the occipital region of his brain. If the seizures couldn’t be controlled, there was a strong possibility that he would develop abnormally. “My son was a zombie.”
Today, that 20-month- old child is thriving. He is doing everything they said he wouldn’t: He is walking, eating and shows no signs of developmental deficits.
A Mother in Action
“My son got sick and I had to be a little bit of a bandit and take it into my own hands.” In those frightening days at the hospital and back at home trying to help her child, Annabelle was driven and tireless in her efforts. She was frightened but focused. As a mother, she was aware of studies that showed CBD had promise in treating seizures. As a scientist, she meticulously researched CBD and its related products. She ultimately came to the conclusion that she needed to try CBD to help control her son’s seizures. The CBD could reduce the frequency and duration of his seizures, but she was dissatisfied with the delivery, potency and transparency of available CBD products.
So, as a scientist and a mother, she developed Masaya CBD.
About Masaya CBD
Masaya CBD is a patent-pending formulation pairing CBD with a medium that accentuates neuroprotectivity, allowing the it to have a dramatically more rapid and more efficient impact. It has twice the potency of any other product on the market today without THC or any other additives. In addition to controlling seizures, CBD is showing great promise for reducing the symptoms of ALS and Parkinson’s Disease. It has also
been shown to reduce chronic pain. The proven track record of CBD with the dramatic improvements in content and delivery made by Masaya is a game changer, and Masaya is poised at the forefront of the CBD industry.
About Annabelle Manalo
Annabelle earned her bachelor's degree in biology from Eastern Kentucky University with honors. She began her graduate work at Georgetown University in Neuroscience where her research focused on the partitioning of the thalamus by the Eph-Ephrin Receptors and Ligands. She is a PhD candidate and Developmental Biologist, focusing her work on mechanisms related to microtubule-targeted chemotherapies at Vanderbilt University in Nashville,
“Masaya means happy.”